Smith & Nephew PLC SNN:NYSE
RT Quote | Last NASDAQ LS, VOL From CTA | USD
After Hours: Last | 4:00 PM EDT29.93UNCH (UNCH)
Volume
1,582
Close
29.93
+0.57 (+1.94%)
+0.57 (+1.94%)Volume
1,376,307
52 week range
28.40 - 38.79
- Open29.45
- Day High30.00
- Day Low29.44
- Prev Close29.36
- 52 Week High38.79
- 52 Week High Date09/09/25
- 52 Week Low28.40
- 52 Week Low Date06/18/25
Latest On Smith & Nephew PLC
Key Stats
- Market Cap12.723B
- Shares Out425.10M
- 10 Day Average Volume1.08M
- Dividend0.78
- Dividend Yield2.61%
- Beta0.59
Latest On Smith & Nephew PLC
KEY STATS
- Open29.45
- Day High30.00
- Day Low29.44
- Prev Close29.36
- 52 Week High38.79
- 52 Week High Date09/09/25
- 52 Week Low28.40
- 52 Week Low Date06/18/25
- Market Cap12.723B
- Shares Out425.10M
- 10 Day Average Volume1.08M
- Dividend0.78
- Dividend Yield2.61%
- Beta0.59
RATIOS/PROFITABILITY
- EPS (TTM)1.43
- P/E (TTM)20.89
- Fwd P/E (NTM)13.20
- EBITDA (TTM)1.606B
- ROE (TTM)11.84%
- Revenue (TTM)6.164B
- Gross Margin (TTM)68.01%
- Net Margin (TTM)10.14%
- Debt To Equity (MRQ)62.90%
EVENTS
- Earnings Date-
- Ex Div Date03/27/2026
- Div Amount0.482
- Split Date-
- Split Factor-
Content From Our Affiliates
Related Video
watch now
Profile
MORESmith & Nephew plc is a portfolio medical technology company. The Company is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, which includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilize severe fractures and correct bone deformities; Sports Medicine & ENT...
Rupert Soames OBE
Non-Executive Independent Chairman of the Board
Deepak Nath
Chief Executive Officer, Executive Director
John Rogers
Chief Financial Officer, Executive Director
Helen Barraclough
Group General Counsel, Company Secretary
Address
Building 5, Croxley Park, Hatters Lane
Watford
WD18 8YE
United Kingdom